StrainX Bioworks has raised $13 million in a funding round co-led by Prime Venture Partners and Leo Capital. The synthetic biology startup said the funds will be used to expand R&D capabilities, scale fermentation infrastructure and grow engineering and scientific teams. StrainX added that it will also use the capital to accelerate global commercialisation efforts.